United States Herceptin Market Size, Share, Statistics, Insights
United States Herceptin Market is anticipated to reach USD 2048.9 million by 2035, growing at a CAGR of 4.69% from 2025 to 2035. The expansion of the United States herceptin market is propelled by the growing prevalence of breast cancer that is HER2-positive and the growing knowledge of targeted cancer treatments.